Overactive Bladder - Results from #1640

Vesico-ureteral reflux in women with idiopathic high-pressure detrusor overactivity: Prevalence, bladder function, and effect on the upper urinary tract - Abstract July 10, 2014

Maximum bladder volume as surrogate screening test for detrusor overactivity - Abstract July 9, 2014

Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women - Abstract July 8, 2014

Neuromodulation by surface electrical stimulation of peripheral nerves for reduction of detrusor overactivity in patients with spinal cord injury: A pilot study - Abstract July 5, 2014

Botulinum neurotoxin type A in neurogenic detrusor overactivity: Consensus paper of the Working Group Neuro-Urology of the DMGP - Abstract July 3, 2014

Success rate and patients' satisfaction following intradetrusor dysport injection in patients with detrusor overactivity: A comparative study of idiopathic and neurogenic types of detrusor overactivity - Abstract July 2, 2014

Current and future drugs for treatment of MS-associated bladder dysfunction - Abstract July 2, 2014

Diagnosis & treatment algorithm: AUA/SUFU Guideline on non-neurogenic overactive bladder in adults July 1, 2014

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline July 1, 2014

AUA/SUFU validate peripheral tibial nerve stimulation (PTNS) for the treatment of overactive bladder in newly published guidelines July 1, 2014

Development and psychometric evaluation of the urgency questionnaire for evaluating severity and health-related quality of life impact of urinary urgency in overactive bladder - Abstract June 30, 2014

Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: Results of a population-based survey - Abstract June 27, 2014

Fesoterodine prescription fill patterns and evaluation of the YourWay patient support plan for patients with overactive bladder symptoms and physicians - Abstract June 27, 2014

Use of non-invasive uroflowmetry with simultaneous electromyography to monitor patient response to treatment for lower urinary tract conditions - Abstract June 26, 2014

Botulinum toxin A's expanding role in the management of pediatric lower urinary tract dysfunction - Abstract June 25, 2014

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER - Abstract June 23, 2014

The odd sibling: Features of β3-adrenoceptor pharmacology - Abstract June 21, 2014

The patient perspective on overactive bladder: A mixed-methods needs assessment - Abstract June 19, 2014

Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: A randomized controlled trial - Abstract June 18, 2014

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder - Abstract June 18, 2014

Page 83 of 122